What You Should Know:
Evidation, the company that connects directly with individuals to measure health in everyday life, has launched FluSmart, a digital flu monitoring program that brings together individuals, researchers, and public and private organizations to understand flu at its earliest stages.
Evidation has developed machine learning detection models to compare flu and COVID and validated and extended this work with collaborators. Evidation will use permissioned data from
Read More
Arine, Gemini Health Partner to Optimize Medications While Lowering Prescription Drug Costs
What You Should Know:
- Arine - a next-generation medication intelligence company - and Gemini - a drug cost transparency platform - announced an integration that supports Blue Shield of California (Blue Shield) by combining each platform’s unique technology to deliver value-based care.
- The collaboration incorporates cost transparency information into Arine’s medication intelligence platform to empower care teams to provide highly personalized, data-driven medication consultations for
Read More
ObvioHealth & Oracle Collaborate to Seamlessly Integrate Diverse Data Sets Into Decentralized Clinical Trials in APAC
What You Should Know:
- Today, ObvioHealth and Oracle have announced a partnership to enable the rapid collection, integration and analysis of this complex data to get breakthrough therapies to market faster and cheaper within the APAC region. This partnership will integrate ObvioGo, ObvioHealth’s next generation decentralized clinical trial (DCT) platform and mobile app, and Oracle Clinical One Cloud Service, facilitating pharma-grade analytics and reporting that can
Read More
Resilience Lab Joins Aetna In-Network for Mental Health
What You Should Know:
- Resilience Lab, a mental health provider enabling communities of clinicians to improve outcomes and access announced that it has joined Aetna as an in-network mental healthcare provider.
- Resilience now has in-network partnerships with three of the nation’s largest health insurance carriers, including Aetnea, United Healthcare and Humana, allowing them to serve more than 50 million Americans across five northeast states.
- This expansion is a key part of
Read More
COTA Secures New Financing to Accelerate Cancer Research and Treatment Innovation
What You Should Know:
- COTA, Inc., an oncology real-world data and analytics company, announced its latest financing by an investment fund managed by Deerfield Management and additional capital from existing investors.
- The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.
- Perella Weinberg Partners LP served as exclusive financial advisor and Goodwin Procter
Read More
Teladoc Health Appoints Laizer Kornwasser as President, Enterprise Growth & Global Markets
What You Should Know:
- Teladoc Health announced that is has named Laizer Kornwasser as President, Enterprise Growth & Global Markets, effective October 24, 2022. As President, Laizer will be focused on further unlocking the revenue and growth potential of the company and optimizing performance across Teladoc’s four market channels: US Group Health, International, Hospitals and Health Systems, and BetterHelp.
- Kornwasser joins Teladoc Health from CareCentrix, where he served
Read More
JPMorgan Chase Launches 3 Advanced Primary Care Centers
What You Should Know:
- Vera Whole Health announced a collaboration with Central Ohio Primary Care (COPC) and JPMorgan Chase & Co. to launch three new on-site advanced primary care centers across the company’s Columbus offices.
- These new centers provide a full suite of comprehensive in-person and virtual health and wellness services for more than 20,000 JPMorgan Chase employees. Vera and COPC will provide the same advanced primary care services at two near-site care centers to
Read More
Viome Raises $67M to Expand Microbiome & At-Home Test Kits
What You Should Know:
- Viome Life Sciences, a mission-driven digital health company, announced additional $67M in funding toward its Series C round.
- Led by Bold Capital Group, the $67M raise brings the company’s total funding to over $150M and will be used to support the development of its at-home tests that leverage precision nutrition to improve health and increase longevity by addressing the epidemic of chronic diseases, cancers, and aging.
- Viome will expand its proprietary mRNA
Read More
MEDITECH Taps Innovaccer to Advance Its Population Health Capabilities
What You Should Know:
- MEDITECH today announced it is extending its population health management offering with Expanse Population Insight, powered by the Innovaccer Data Platform.
- Population Insight leverages the power of the Expanse platform for providing care delivery and data analytics with proven expertise in data aggregation and curation.
Expanse Population Features
Expanse Population Insight aggregates data from claims, the EHR, and other sources to provide
Read More
Femtech Market to Reach $22B by 2028
What You Should Know:
- The global femtech market size is expected to grow from $12.65 billion in 2022 to $22.29 billion by 2028, with an estimated CAGR of 9.9% from 2022 to 2028, according to the latest Insight Partners report.
- The report reveals that the global femtech market growth is driven by increasing demand for medical devices used in the female health industry and growing demand for technologically advanced femtech products.
Femtech Market Drivers
The Femtech market
Read More
